The change of gut microbiota in MDD patients under SSRIs treatment
Abstract The alterations in the gut microbiota have been reported to be correlated with the development of depression. The purpose of this study was to investigate the changes of intestinal microbiota in depressed patients after antidepressant treatment. We recruited 30 MDD patients (MDD group) and...
Guardado en:
Autores principales: | Yang Shen, Xiao Yang, Gaofei Li, Jiayu Gao, Ying Liang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0016a89170534fbc8254b14ed0782a67 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Characteristics of PMS Co-Morbid with MDD and Effectiveness of SSRIs in its Treatment
por: Yakimova R., et al.
Publicado: (2020) -
Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study
por: Yuan H, et al.
Publicado: (2019) -
The prognosis and changes of regional brain gray matter volume in MDD with gastrointestinal symptoms
por: Liu P, et al.
Publicado: (2019) -
Resting-state functional changes in the precuneus within first-episode drug-naive patients with MDD
por: Li G, et al.
Publicado: (2018) -
Efficacy comparison of duloxetine and SSRIs at doses approved in Japan
por: Harada E, et al.
Publicado: (2015)